Runben Biotechnology (SH:603193) Shang Hai Zheng Quan Bao·2025-09-03 22:48Meeting Overview - The second extraordinary general meeting of shareholders was held on September 3, 2025, at the company's conference room in Guangzhou, Guangdong Province [2][3] - The meeting was chaired by the company's chairman, Zhao Guiqin, and utilized a combination of on-site and online voting methods, complying with the Company Law and the company's articles of association [2][3] Attendance - All 5 current directors attended the meeting, including 2 independent directors [3] - All 3 current supervisors and the board secretary, Wu Weibin, were also present [3] Resolutions Passed - The following proposals were approved during the meeting: 1. Proposal on the 2025 semi-annual profit distribution plan [3] 2. Proposal to cancel the supervisory board and amend the articles of association [3] 3. Proposal to amend the rules of procedure for shareholder meetings [4] 4. Proposal to amend the rules of procedure for board meetings [4] 5. Proposal to amend the independent director work system [4] 6. Proposal to amend the external guarantee management system [4] 7. Proposal to amend the external investment management system [4] 8. Proposal to amend the related party transaction management system [4] 9. Proposal to amend the selection system for accounting firms [4] 10. Proposal to amend the behavior norms for controlling shareholders and actual controllers [5] 11. Proposal to amend the implementation details of the cumulative voting system [5] 12. Proposal to amend the management system for raised funds [5] Legal Verification - The meeting was witnessed by Guangdong Guangxin Junda Law Firm, with lawyers Zhang Wei and Ma Xiaoxi confirming that the meeting's procedures, attendance qualifications, and voting results were in compliance with legal regulations and the company's articles of association [5]